review of glp 1 GLP-1-based therapies for diabetes, obesity and beyond IUPHAR review – Glucagon-like peptide-1

Meet our medical team at the Aptos clinic or by secure video call

Medication costs fluctuate: The price might change based on the dose you get from the medication

doi: 10.1111/dom.15167

Following the ingestion of carbohydrates and fats, GLP-1 is released and exerts multiple physiological effects essential for maintaining glucose homeostasis (Bullock et al., 1996)

RuddKEJohnsonSCAgesaKMShackelfordKATsoiDKievlanDRet al

While traditional recommendations have focused on the stepwise addition of therapy, allowing for clear delineation of positive and negative effects of new drugs, there are data to suggest benefits of combination approaches in diabetes care